HTFL Stock Analysis: Buy, Sell, or Hold?
HTFL - Heartflow, Inc. Common Stock
$27.97
-2.75 (-8.94%)
▼
5d:
-20.05%
30d:
-5.36%
90d:
+14.14%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When HTFL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HTFL is down 20.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HTFL is down 20.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HTFL is currently trading at $27.96, which is considered oversold relative to its 30-day fair value range of $28.86 to $33.75.
Technical Outlook: Technically, HTFL is showing sideways momentum. The price is currently testing key support at $27.68. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.00 (+32.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HTFL is showing sideways momentum. The price is currently testing key support at $27.68. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.9% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $37.00 (+32.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$28.86 -
$33.75
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.9%)
- BULLISH: Trading 32.3% below Wall St target ($37.00)
- WARNING: Recommendation downgraded due to -20.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$28.86 -
$33.75
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$27.68
Resistance Level
$32.60
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-105.77
Wall Street Target
$37.00
(+32.3%)
Revenue Growth (YoY)
41.3%
Profit Margin
-58.4%
Share & Embed Analysis
Last updated: July 02, 2026 10:32 PM ET
Data refreshes hourly during market hours. Next update: 11:32 PM
Data refreshes hourly during market hours. Next update: 11:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HTFL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
John C.M. Farquhar
SELL
22562 shares
2026-04-10
Campbell Rogers
SELL
64533 shares
2026-04-01
Campbell Rogers
SELL
64533 shares
2026-03-19
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |